Precorneal residence time of artificial tears measured in dry eye subjects

Optometry and Vision Science

Volumn 85, Issue 8, 2008, Pages 725-731

  Paugh, Jerry R ^a   Nguyen, Andrew Loc ^b   Ketelson, Howard A ^c   Christensen, Mike T ^c   Meadows, David L ^c  

^a SOUTHERN CALIFORNIA COLLEGE OF OPTOMETRY   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c Alcon Research   (United States)

Author keywords

Artificial tears; Dry eye; FITC dextran; Fluorometer; Residence time

Indexed keywords

ADHESIVE FORMULATION; ARTIFICIAL TEARS; CARBOXY METHYLCELLULOSE; CROSS-OVER; CUMULATIVE EFFECTS; DRY EYE; FITC-DEXTRAN; HYDROXYPROPYL METHYLCELLULOSE; LOW VISCOSITY; MEIBOMIAN GLANDS; OIL EMULSIONS; P-VALUE; PROPYLENE GLYCOLS; PSEUDOPLASTICITY; RESIDENCE TIME; SPREADING CHARACTERISTICS; STERILE CONDITIONS;

DEXTRAN; EMULSIFICATION; EMULSIONS; ETHYLENE GLYCOL; FLUOROMETERS; GLUCOSE; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; PROPYLENE;

VISCOSITY;

ARTIFICIAL TEAR; CARBOXYMETHYLCELLULOSE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HYDROXYPROPYLMETHYLCELLULOSE; INTRALIPID; MACROGOL; PROPYLENE GLYCOL; SODIUM CHLORIDE; DEXTRAN; DRUG DERIVATIVE; EYE DROPS; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRY EYE; FEMALE; FLUOROMETER; FLUOROMETRY; HUMAN; MALE; MEIBOMIAN GLAND; MEIBOMIAN GLAND DYSFUNCTION; MOLECULAR WEIGHT; PRIORITY JOURNAL; SEBACEOUS GLAND DISEASE; VISCOSITY; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORNEA; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FLUOROPHOTOMETRY; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TIME; VISUAL SYSTEM EXAMINATION;

ADULT; AGED; CORNEA; CROSS-OVER STUDIES; DEXTRANS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DOUBLE-BLIND METHOD; DRY EYE SYNDROMES; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; FLUOROPHOTOMETRY; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; TIME FACTORS; VISCOSITY;

EID: 52049088803     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e3181824de3     Document Type: Article

References (22)

1. Hom MM, Martinson JR, Knapp LL, Paugh JR. Prevalence of Meibomian gland dysfunction. Optom Vis Sci 1990;67:710-12.
2. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136: 318-26.
3. Dudinski O, Finnin BC, Reed BL. Acceptability of thickened eye drops to human subjects. Curr Ther Res 1983;33:322-37.
4. Ridder WH III, Tomlinson A, Paugh J. Effect of artificial tears on visual performance in subjects with dry eye. Optom Vis Sci 2005;82: 835-42.
5. Greaves JL, Wilson CG, Galloway NR, Birmingham AT, Olejnik O. A comparison of the precorneal residence of an artificial tear preparation in patients with keratoconjunctivitis sicca and normal volunteer subjects using gamma scintigraphy. Acta Ophthalmol (Copenh) 1991;69:432-6.
6. Snibson GR, Greaves JL, Soper ND, Tiffany JM, Wilson CG, Bron AJ. Ocular surface residence times of artificial tear solutions. Cornea 1992;11:288-93.
7. Ludwig A, van Ooteghem M. The evaluation of viscous ophthalmic vehicles by slit lamp fluorophotometry in humans. Int J Pharm 1989; 54:95-102.
8. Meadows DL, Paugh JR, Joshi A, Mordaunt J. A novel method to evaluate residence time in humans using a nonpenetrating fluorescent tracer. Invest Ophthalmol Vis Sci 2002;43:1032-9.
9. Paugh JR. Rheological phenomena on the ocular surface studied by fluorescence techniques. PhD Thesis. University of New South Wales; 1998.
10. Pflugfelder SC, Tseng SC, Sanabria O, Kell H, Garcia CG, Felix C, Feuer W, Reis BL. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea 1998;17:38-56.
11. Schein OD, Tielsch JM, Munoz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 1997;104:1395-401.
12. Paugh JR, Nguyen AL. Validation of the modified Schein Dry Eye Symptom Questionnaire. Invest Ophthalmol Vis Sci 2006;47: ARVO E-abstract 276.
13. Yokoi N, Takehisa Y, Kinoshita S. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye. Am J Ophthalmol 1996;122:818-24.
14. Efron N, Morgan PB, Katsara SS. Validation of grading scales for contact lens complications. Ophthalmic Physiol Opt 2001;21: 17-29.
15. Lemp MA. Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J 1995;21:221-32.
16. Paugh JR, Marsden HJ, Edrington TB, Deland PN, Simmons PA, Vehige JG. A pre-application drop containing carboxymethylcellu-lose can reduce multipurpose solution-induced corneal staining. Op-tom Vis Sci 2007;84:65-71.
17. Macri A, Rolando M, Pflugfelder S. A standardized visual scale for evaluation of tear fluorescein clearance. Ophthalmology 2000;107: 1338-43.
18. Norn M. Meibomian orifices and Marx's line. Studied by triple vital staining. Acta Ophthalmol (Copenh) 1985;63:698-700.
19. Mackie IA, Seal DV. The questionably dry eye. Br J Ophthalmol 1981;65:2-9.
20. Webber WR, Jones DP, Wright P.Fluorophotometric measurements of tear turnover rate in normal healthy persons: evidence for a circadian rhythm. Eye 1987;1(Pt 5):615-20.
21. Fraunfelder FT. Extraocular fluid dynamics: how best to apply topical ocular medication. Trans Am Ophthalmol Soc 1976;74:457-87.
22. Snibson GR, Greaves JL, Soper ND, Prydal JI, Wilson CG, Bron AJ. Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy. Eye 1990;4(Pt 4):594-602.